share_log

Adial Pharmaceuticals Q1 EPS $(2.19) Misses $(0.35) Estimate

Adial Pharmaceuticals Q1 EPS $(2.19) Misses $(0.35) Estimate

Adial Pharmicals第一季度每股收益美元(2.19美元)未達到預期(0.35美元)
Benzinga ·  05/15 08:45

Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(2.19) per share which missed the analyst consensus estimate of $(0.35) by 525.71 percent. This is a 20.36 percent increase over losses of $(2.75) per share from the same period last year.

Adial Pharmicals(納斯達克股票代碼:ADIL)公佈的季度虧損爲每股2.19美元,比分析師普遍預期的0.35美元(0.35美元)低525.71%。這比去年同期每股虧損2.75美元(2.75美元)增長了20.36%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論